Richard Ransohoff

Articles in Scholarly Journals [Incomplete List]

  1. Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration
    Clinical and Developmental Immunology, vol. 2008, Article ID 384982, 8 pages, 2008
  2. Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale
    Brain Pathology, vol. 17, no. 2, pp. 243–250, 2007
  3. "Doing the locomotion" with the multistep paradigm
    Blood, vol. 109, no. 4, pp. 1342–1343, 2007
  4. Natalizumab for Multiple Sclerosis
    New England Journal of Medicine, vol. 356, no. 25, pp. 2622–2629, 2007
  5. Evidence for synaptic stripping by cortical microglia
    Glia, vol. 55, no. 4, pp. 360–368, 2007
  6. “Thinking without thinking” about natalizumab and PML
    Journal of the Neurological Sciences, vol. 259, no. 1-2, pp. 50–52, 2007
  7. The expression and function of chemokines involved in CNS inflammation
    Trends in Pharmacological Sciences, vol. 27, no. 1, pp. 48–55, 2006
  8. CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood–brain barrier in vitro
    Cellular Immunology, vol. 243, no. 1, pp. 19–29, 2006
  9. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details
    Current Opinion in Immunology, vol. 18, no. 6, pp. 683–689, 2006
  10. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis
    Trends in Immunology, vol. 27, no. 4, pp. 167–168, 2006
  11. Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation
    Journal of Neuroimmunology, vol. 179, no. 1-2, pp. 132–144, 2006
  12. CC Chemokine Receptor 2 is Protective Against Noise-Induced Hair Cell Death: Studies in CX3CR1+/GFP Mice
    Journal of the Association for Research in Otolaryngology, vol. 7, no. 4, pp. 361–372, 2006
  13. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2
    Glia, vol. 54, no. 5, pp. 471–483, 2006
  14. The Many Roles of Chemokines and Chemokine Receptors in Inflammation
    New England Journal of Medicine, vol. 354, no. 6, pp. 610–621, 2006
  15. Control of microglial neurotoxicity by the fractalkine receptor
    Nature Neuroscience, vol. 9, no. 7, Article ID nn1715, 7 pages, 2006
  16. Isolation of murine microglial cells for RNA analysis or flow cytometry
    Nature Protocols, vol. 1, no. 4, Article ID nprot.2006.327, 4 pages, 2006
  17. Interferon- -inducible Protein (IP)-10 mRNA Stabilized by RNA-binding Proteins in Monocytes Treated with S100b
    Journal of Biological Chemistry, vol. 281, no. 42, pp. 31212–31221, 2006
  18. BMC Immunology, vol. 7, no. 1, p. 14, 2006
  19. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system
    The FASEB Journal, vol. 20, no. 7, pp. 896–905, 2006
  20. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis
    Brain, vol. 129, no. 1, pp. 212–223, 2005
  21. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
    Brain, vol. 129, no. 1, pp. 200–211, 2005
  22. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice
    The FASEB Journal, vol. 19, no. 7, pp. 761–772, 2005
  23. Alternative and Accessory Pathways in the Regulation of IFN--Mediated Gene Expression
    Journal of Interferon Cytokine Research, vol. 25, no. 12, pp. 788–798, 2005
  24. Immunologic Correlates of MS Pathologic Subtypes
    Multiple Sclerosis, vol. 11, no. 1, pp. 101–102, 2005
  25. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23
    Journal of Neurochemistry, vol. 95, no. 2, pp. 331–340, 2005
  26. Natalizumab and PML
    Nature Neuroscience, vol. 8, no. 10, Article ID nn1005-1275, 1 pages, 2005
  27. Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells
    Glia, vol. 53, no. 1, pp. 81–91, 2005
  28. Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma
    The Journal of Comparative Neurology, vol. 489, no. 2, pp. 180–194, 2005
  29. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation
    International Journal of Cancer, vol. 114, no. 4, pp. 598–605, 2005
  30. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination
    Journal of the Neurological Sciences, vol. 228, no. 1, pp. 3–5, 2005
  31. Hashimoto's encephalopathy: A relapsing form of acute disseminated encephalomyelitis
    Journal of the Neurological Sciences, vol. 235, no. 1-2, pp. 75–76, 2005
  32. Fluid in the flute: Reversible hydromyelia
    Journal of the Neurological Sciences, vol. 236, no. 1-2, pp. 85–86, 2005
  33. Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients
    Journal of Neuroimmunology, vol. 163, no. 1-2, pp. 179–184, 2005
  34. polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis
    Journal of Neuroimmunology, vol. 169, no. 1-2, pp. 137–143, 2005
  35. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms
    Trends in Immunology, vol. 26, no. 9, pp. 485–495, 2005
  36. Taking Two TRAILS
    Neuron, vol. 46, no. 3, pp. 355–356, 2005
  37. VEGF-mediated inflammation precedes angiogenesis in adult brain
    Experimental Neurology, vol. 187, no. 2, pp. 388–402, 2004
  38. The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal
    Trends in Immunology, vol. 25, no. 3, pp. 132–137, 2004
  39. New directions in MS therapeutics: vehicles of hope
    Trends in Immunology, vol. 25, no. 12, pp. 632–636, 2004
  40. The blood–brain barrier as target of multiple sclerosis research and therapyReport of an international scientific meeting, Würzburg, January 23/24, 2004
    Journal of Neuroimmunology, vol. 152, no. 1-2, pp. 1–4, 2004
  41. CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer
    Journal of Neuroimmunology, vol. 153, no. 1-2, pp. 150–157, 2004
  42. Analysis of leukocyte extravasation across the blood-brain barrier: Conceptual and technical aspects
    Current Allergy and Asthma Reports, vol. 4, no. 1, pp. 65–73, 2004
  43. Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response
    The Journal of Comparative Neurology, vol. 474, no. 4, pp. 469–486, 2004
  44. Induction of glial L-CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis
    Glia, vol. 46, no. 1, pp. 84–94, 2004
  45. Expression of CCR7 in multiple sclerosis: Implications for CNS immunity
    Annals of Neurology, vol. 55, no. 5, pp. 627–638, 2004
  46. Defining interferon ? response status in multiple sclerosis patients
    Annals of Neurology, vol. 56, no. 4, pp. 548–555, 2004
  47. Treatment with Soluble Tumor Necrosis Factor Receptor (sTNFR):Fc/p80 Fusion Protein Ameliorates Relapsing-remitting Experimental Autoimmune Encephalomyelitis and Decreases Chemokine Expression
    Autoimmunity, vol. 37, no. 6-7, pp. 465–471, 2004
  48. Inhibitor of  B kinase is required to activate a subset of interferon  -stimulated genes
    Proceedings of the National Academy of Sciences, vol. 101, no. 21, pp. 7994–7998, 2004
  49. MCP-1 and CCR2 Contribute to Non-Lymphocyte-Mediated Brain Disease Induced by Fr98 Polytropic Retrovirus Infection in Mice: Role for Astrocytes in Retroviral Neuropathogenesis
    Journal of Virology, vol. 78, no. 12, pp. 6449–6458, 2004
  50. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis
    Journal of Leukocyte Biology, vol. 77, no. 2, pp. 229–237, 2004
  51. The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis
    Journal of Experimental Medicine, vol. 199, no. 2, pp. 185–197, 2004
  52. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
    European Journal of Neurology, vol. 11, no. 7, pp. 445–449, 2004
  53. TNF- Microinjection Upregulates Chemokines and Chemokine Receptors in the Central Nervous System Without Inducing Leukocyte Infiltration
    Journal of Interferon Cytokine Research, vol. 23, no. 8, pp. 457–466, 2003
  54. Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritis
    Acta Neurologica Scandinavica, vol. 107, no. 3, pp. 221–227, 2003
  55. Snip-snip, kill-kill: truncated SDF-1 and HIV-associated neurodegeneration
    Nature Neuroscience, vol. 6, no. 10, Article ID nn1003-1009, 2 pages, 2003
  56. Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune Encephalomyelitis
    Scandinavian Journal of Immunology, vol. 58, no. 1, pp. 81–88, 2003
  57. Three or more routes for leukocyte migration into the central nervous system
    Nature Reviews Immunology, vol. 3, no. 7, Article ID nri1130, 12 pages, 2003
  58. Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS)
    Neuropathology and Applied Neurobiology, vol. 29, no. 6, pp. 584–595, 2003
  59. Expression of CCR2, CCR5, and CXCR3 by CD4+ T Cells is Stable During a 2-Year Longitudinal Study but Varies Widely Between Individuals
    Journal of Neurovirology, vol. 9, no. 3, pp. 291–299, 2003
  60. CCL2 Transgene Expression in the Central Nervous System Directs Diffuse Infiltration of CD45highCD11b+ Monocytes and Enhanced Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
    Journal of Neurovirology, vol. 9, no. 6, pp. 623–636, 2003
  61. Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin
    Proceedings of the National Academy of Sciences, vol. 100, no. 14, pp. 8389–8394, 2003
  62. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice
    European Journal of Immunology, vol. 33, no. 7, pp. 2022–2032, 2003
  63. Chemokine
    Der Nervenarzt, vol. 74, no. 10, pp. 850–857, 2003
  64. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines
    Journal of Molecular and Cellular Cardiology, vol. 35, no. 11, pp. 1375–1384, 2003
  65. Interferon-$beta;1a does not reduce expression of CCR5 and CXCR3 on circulating T cells
    Journal of Neuroimmunology, vol. 141, no. 1-2, pp. 150–154, 2003
  66. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
    Seminars in Immunology, vol. 15, no. 1, pp. 23–32, 2003
  67. Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytes
    Methods, vol. 29, no. 4, pp. 319–325, 2003
  68. The Chemokine Receptor CXCR2 Controls Positioning of Oligodendrocyte Precursors in Developing Spinal Cord by Arresting Their Migration
    Cell, vol. 110, no. 3, pp. 373–383, 2002
  69. Experimental Autoimmune Encephalomyelitis: CC Chemokine Receptor Expression by Trafficking Cells
    Journal of Autoimmunity, vol. 19, no. 4, pp. 175–181, 2002
  70. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion
    Journal of Neuroscience Research, vol. 68, no. 6, pp. 691–702, 2002
  71. Interferon Signaling Is Dependent on Specific Tyrosines Located within the Intracellular Domain of IFNAR2c. EXPRESSION OF IFNAR2c TYROSINE MUTANTS IN U5A CELLS
    Journal of Biological Chemistry, vol. 277, no. 2, pp. 1493–1499, 2002
  72. Requirement of Phosphoinositide 3-Kinase and Akt for Interferon-beta -mediated Induction of the beta -R1 (SCYB11) Gene
    Journal of Biological Chemistry, vol. 277, no. 41, pp. 38456–38461, 2002
  73. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking
    Clinical and Experimental Immunology, vol. 129, no. 3, pp. 510–518, 2002
  74. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
    Journal of Neuroimmunology, vol. 127, no. 1-2, pp. 59–68, 2002
  75. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES
    Journal of Neuroimmunology, vol. 128, no. 1-2, pp. 16–22, 2002
  76. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia
    Neuroscience, vol. 112, no. 3, pp. 487–497, 2002
  77. Growth factor treatment of demyelinating disease: at last, a leap into the light
    Trends in Immunology, vol. 23, no. 11, pp. 512–516, 2002
  78. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10
    Brain, vol. 125, no. 4, pp. 823–834, 2002
  79. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
    Brain, vol. 125, no. 7, pp. 1450–1461, 2002
  80. The Chemokine System in Neuroinflammation: An Update
    The Journal of Infectious Diseases, vol. 186, no. S2, pp. S152–S156, 2002
  81. Chemokine Expression in the Central Nervous System of Mice with a Viral Disease Resembling Multiple Sclerosis: Roles of CD4+ and CD8+ T Cells and Viral Persistence
    Journal of Virology, vol. 76, no. 5, pp. 2217–2224, 2002
  82. Human Parainfluenza Virus Type 3 Inhibits Gamma Interferon-Induced Major Histocompatibility Complex Class II Expression Directly and by Inducing Alpha/Beta Interferon
    Journal of Virology, vol. 75, no. 3, pp. 1124–1131, 2001
  83. TNF-alpha mediates SDF-1alpha-induced NF-kappaB activation and cytotoxic effects in primary astrocytes
    Journal of Clinical Investigation, vol. 108, no. 3, pp. 425–435, 2001
  84. Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis
    Journal of Experimental Medicine, vol. 193, no. 6, pp. 713–726, 2001
  85. Regulation of monocyte chemoattractant protein (MCP)-1 transcription by interferon-gamma (IFN-gamma) in human astrocytoma cells: postinduction refractory state of the gene, governed by its upstream elements
    The FASEB Journal, vol. 15, no. 2, pp. 383–392, 2001
  86. Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury
    Neuroreport, vol. 12, no. 3, pp. 601–606, 2001
  87. Constitutive Expression of Growth-related Oncogene and Its Receptor in Oligodendrogliomas
    Neurosurgery, vol. 48, no. 4, pp. 864–874, 2001
  88. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
    European Journal of Neurology, vol. 8, no. 6, pp. 665–672, 2001
  89. Stat1-independent regulation of gene expression in response to IFN-gamma
    Proceedings of the National Academy of Sciences, vol. 98, no. 12, pp. 6674–6679, 2001
  90. A Role for NF-kappa B in the Induction of beta -R1 by Interferon-beta
    Journal of Biological Chemistry, vol. 276, no. 48, pp. 44365–44368, 2001
  91. A Real-Time Insight Into Disease Progression and the Role of Axonal Injury in Multiple Sclerosis
    Archives of Neurology, vol. 58, no. 1, pp. 37–39, 2001
  92. Investigating Chemokines and Chemokine Receptors in Patients With Multiple Sclerosis: Opportunities and Challenges
    Archives of Neurology, vol. 58, no. 12, pp. 1975–1980, 2001
  93. TNF-a down-regulates CXCR4 expression in primary murine astrocytes
    Brain Research, vol. 888, no. 1, pp. 1–10, 2001
  94. Chemokine-based therapies for MS: how do we get there from here?
    Trends in Immunology, vol. 22, no. 11, pp. 591–593, 2001
  95. Antigen recognition by T cells: a strong sense of structure
    Trends in Immunology, vol. 22, no. 11, pp. 599–601, 2001
  96. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration
    Journal of Neuroimmunology, vol. 109, no. 2, pp. 221–227, 2000
  97. Sequential expression of chemokines in experimental autoimmune neuritis
    Journal of Neuroimmunology, vol. 110, no. 1-2, pp. 121–129, 2000
  98. Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers
    Journal of Biomedical Materials Research, vol. 49, no. 3, pp. 396–408, 2000
  99. TGF?1 selectively up-regulates CCR1 expression in primary murine astrocytes
    Glia, vol. 30, no. 1, pp. 1–10, 2000
  100. Role of the Intracellular Domain of the Human Type I Interferon Receptor 2 Chain (IFNAR2c) in Interferon Signaling. EXPRESSION OF IFNAR2c TRUNCATION MUTANTS IN U5A CELLS
    Journal of Biological Chemistry, vol. 275, no. 31, pp. 23981–23985, 2000
  101. Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis
    Journal of Experimental Medicine, vol. 191, no. 10, pp. 1625–1630, 2000
  102. Chemokine receptor antagonism as a new therapy for multiple sclerosis
    Expert Opinion on Investigational Drugs, vol. 9, no. 5, pp. 1079–1097, 2000
  103. Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
    The Neuroscientist, vol. 5, no. 1, pp. 48–57, 1999
  104. Tumor Necrosis Factor-alpha Signals to the IFN-gamma Receptor Complex to Increase Stat1alpha Activation
    Journal of Interferon Cytokine Research, vol. 19, no. 7, pp. 731–740, 1999
  105. Current Opinion in Neurology, vol. 12, no. 3, pp. 295–302, 1999
  106. Induction of beta -R1/I-TAC by Interferon-beta Requires Catalytically Active TYK2
    Journal of Biological Chemistry, vol. 274, no. 4, pp. 1891–1897, 1999
  107. Catalytically Active TYK2 Is Essential for Interferon-beta -mediated Phosphorylation of STAT3 and Interferon-alpha Receptor-1 (IFNAR-1) but Not for Activation of Phosphoinositol 3-Kinase
    Journal of Biological Chemistry, vol. 274, no. 45, pp. 32507–32511, 1999
  108. Conference Paper
    Journal of Neuroimmunology, vol. 97, no. 1-2, pp. 4–8, 1999
  109. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
    Journal of Neuroimmunology, vol. 97, no. 1-2, pp. 119–128, 1999
  110. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines
    Journal of Neuroimmunology, vol. 98, no. 1, pp. 57–68, 1999
  111. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?
    Trends in Neurosciences, vol. 21, no. 4, pp. 154–159, 1998
  112. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury
    Journal of Neuroscience Research, vol. 53, no. 3, pp. 368–376, 1998
  113. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines
    Journal of Neuroscience Research, vol. 54, no. 2, pp. 169–180, 1998
  114. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma
    Acta Neuropathologica, vol. 95, no. 1, pp. 98–103, 1998
  115. Axonal Transection in the Lesions of Multiple Sclerosis
    New England Journal of Medicine, vol. 338, no. 5, pp. 278–285, 1998
  116. Cellular Responses to Interferons and Other Cytokines: The JAK-STAT Paradigm
    New England Journal of Medicine, vol. 338, no. 9, pp. 616–618, 1998
  117. Expression of Chemokines RANTES, MIP-1α and GRO-α Correlates with Inflammation in Acute Experimental Autoimmune Encephalomyelitis
    Neuroimmunomodulation, vol. 5, no. 3-4, pp. 166–171, 1998
  118. Management of Multiple Sclerosis
    New England Journal of Medicine, vol. 337, no. 22, pp. 1604–1611, 1997
  119. Chemokines in immune-mediated inflammation of the central nervous system
    Cytokine & Growth Factor Reviews, vol. 7, no. 1, pp. 35–46, 1996
  120. Transcriptional regulation of chemokine gene expression in astrocytes
    Journal of Neuroscience Research, vol. 45, no. 6, pp. 758–769, 1996
  121. Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis
    Annals of Neurology, vol. 40, no. 4, pp. 618–627, 1996
  122. Characterization of beta -R1, a Gene That Is Selectively Induced by Interferon beta (IFN-beta ) Compared with IFN-alpha
    Journal of Biological Chemistry, vol. 271, no. 37, pp. 22878–22884, 1996
  123. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48- kD DNA-binding protein, ISGF3-gamma
    Journal of Experimental Medicine, vol. 182, no. 5, pp. 1517–1525, 1995
  124. The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis
    Annals of Neurology, vol. 37, no. 1, pp. 7–15, 1995
  125. Central Nervous System Chemokine mRNA Accumulation Follows Initial Leukocyte Entry at the Onset of Acute Murine Experimental Autoimmune Encephalomyelitis
    Brain, Behavior, and Immunity, vol. 9, no. 4, pp. 315–330, 1995
  126. Regulation and function of central nervous system chemokines
    International Journal of Developmental Neuroscience, vol. 13, no. 3-4, pp. 153–165, 1995
  127. Heat-shock proteins and autoimmunity: Implications for multiple sclerosis
    Annals of Neurology, vol. 34, no. 1, pp. 5–7, 1993
  128. Transforming growth factor-ß1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures
    Brain Research, vol. 585, no. 1-2, pp. 229–236, 1992
  129. Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo
    Journal of Neuroimmunology, vol. 37, no. 3, pp. 169–176, 1992
  130. Interferon-ß specifically inhibits interferon-?-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line
    Journal of Neuroimmunology, vol. 33, no. 2, pp. 103–112, 1991
  131. Human astrocytes proliferate in response to tumor necrosis factor alpha
    Journal of Neuroimmunology, vol. 30, no. 2-3, pp. 239–243, 1990
  132. Vitamin B12 deficiency and multiple sclerosis
    The Lancet, vol. 335, no. 8700, pp. 1285–1286, 1990
  133. Characterization of adult human astrocytes derived from explant culture
    Journal of Neuroscience Research, vol. 27, no. 4, pp. 697–705, 1990
  134. Astrocyte Cultures Derived from Human Brain Tissue Express Angiotensinogen mRNA
    Proceedings of the National Academy of Sciences, vol. 87, no. 15, pp. 5720–5723, 1990
  135. Interferon-ß impairs induction of HLA-DR antigen expression in cultured adult human astrocytes
    Journal of Neuroimmunology, vol. 23, no. 1, pp. 45–53, 1989
  136. Regulation of class II major histocompatibility complex genes: Relation to multiple sclerosis
    Research in Immunology, vol. 140, no. 2, pp. 202–207, 1989
  137. Priming of influenza mRNA transcription is inhibited in CHO cells treated with the methylation inhibitor, Neplanocin A
    Antiviral Research, vol. 7, no. 6, pp. 317–327, 1987